Chinese investment in Europe ticked upward in 2021—but the headline figure obscures a troubling reality for dealmakers hungry for cross-border transactions.
According to a report by Rhodium Group and MERICS, Chinese direct investment in Europe rose 33% to EUR 10.6 billion from EUR 7.9 billion in 2020. That sounds like a recovery. It's not.
Why the Headline Number Misleads
The 2021 figure represents the second-lowest investment total since 2013 and less than a quarter of the EUR 47.4 billion annual peak recorded in 2016. The modest uptick stems almost entirely from one transaction: Hillhouse Capital, the Chinese investment firm controlled by billionaire Zhang Lei, acquired Philips' home appliance business for EUR 3.7 billion. Without that single deal, investment would have barely budged.
This concentration reveals how fragile the recovery remains. The pipeline of new Chinese acquisitions has dried up significantly, leaving European companies hoping for strategic investment or exit opportunities largely disappointed.
The Structural Shift: Greenfield Overtakes M&A
Beyond the headline number, the composition of Chinese investment tells a more consequential story. The acquisition-heavy model that dominated earlier years is giving way to greenfield projects—building operations from scratch rather than buying existing companies.
Greenfield investment reached EUR 3.3 billion in 2021, the highest value ever recorded. Meanwhile, mergers and acquisitions declined as a share of total activity. This shift reflects several pressures: tighter screening regimes in the EU and UK, China's own capital controls, and strategic preferences from Beijing.
Venture Capital Sets Records
Venture capital investment from Chinese entities doubled to EUR 1.2 billion, another historical high. The top recipients were companies in the UK and Germany, concentrated in e-commerce, fintech, gaming, AI, and robotics. Unlike traditional M&A, these investments often take minority stakes and focus on accessing technology or market presence rather than controlling assets.
This VC surge suggests Chinese investors haven't abandoned Europe—they've simply adapted their approach to avoid the political scrutiny that large acquisitions attract.
Our Analysis: What to Watch
The report projects that Chinese investment is unlikely to rebound meaningfully in 2022. Multiple headwinds align against recovery: China's government maintains strict capital controls and financial deleveraging policies. COVID-19 restrictions continue disrupting deal-making logistics. The Ukraine conflict has added geopolitical risk that makes European targets more sensitive.
Perhaps most significantly, expanding screening regimes in the EU and UK create higher barriers for Chinese acquisitions. Regulators increasingly scrutinize investments in technology, infrastructure, and anything with national security implications.
Who should care:
- European companies seeking Chinese partners or buyers:** The M&A window has narrowed considerably. Greenfield projects or minority VC investments are more realistic paths.
- Competitors of Chinese-backed firms:** Fewer acquisitions mean fewer European companies suddenly backed by Chinese capital and market access.
- Policymakers tracking strategic assets:** The greenfield and VC shift means Chinese presence grows through organic build-out, which screening rules often miss.
- Investors in Chinese-backed European plays:** Concentration in single large deals (like Philips) creates volatility. Diversification into smaller greenfield projects is underway but remains modest.
What Happens Next
The structural shift toward greenfield and VC investment likely persists regardless of headline numbers. Beijing's preferences, Western regulatory scrutiny, and the high-water mark of available acquisition targets all point in the same direction.
European dealmakers should adjust expectations. Large acquisition opportunities will remain rare. The action shifts to smaller investments, minority stakes, and organic market entry—which are harder to track and regulate but shape Chinese commercial presence just the same.
Key takeaways
- The 2021 rebound is almost entirely attributable to one EUR 3.7 billion deal
- Greenfield investment hit a record EUR 3.3 billion, signaling a permanent structural shift
- VC investment doubled to EUR 1.2 billion, concentrated in UK and Germany tech sectors
- Screening regimes and capital controls make a 2022 rebound unlikely
- The nature of Chinese investment is changing more than its volume
Frequently asked questions
Why did greenfield investment surpass M&A activity?
Regulatory scrutiny of acquisitions has intensified across the EU and UK, while Chinese capital controls limit outbound deals. Building operations from scratch avoids many of these obstacles.
Which European countries received the most Chinese investment in 2021?
No single country dominated the headline number—the Philips deal involved the Netherlands. However, venture capital investment concentrated in the UK and Germany across technology sectors.
What sectors are Chinese investors targeting?
E-commerce, fintech, gaming, AI, and robotics attracted significant VC investment. Traditional manufacturing and infrastructure deals face the highest regulatory barriers.
Will investment levels recover to 2016 peaks?
Unlikely. Multiple structural factors—capital controls, geopolitical tensions, screening regimes, and fewer available targets—point to sustained lower levels for the foreseeable future.
How does the Ukraine conflict affect Chinese investment prospects?
The war adds geopolitical risk that makes European deals more sensitive. Chinese firms may face reputational and regulatory pressure over any perceived alignment with Russian interests.